Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Safety and efficacy of filgotinib in Asian patients with active rheumatoid arthritis and prior inadequate response or intolerance to biologic DMARDs (bDMARD-IR) enrolled in a global phase 3 trial
- Authors
- 배상철
- Issue Date
- 16-May-2019
- Place
- Seoul Dragon City, Seoul, Korea
- Conference Name
- 제 39 차 춘계학술대회 및 제 13차 국제심포지엄
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.